Neurocrine Biosciences, Inc.

NBIX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$233,000$251,100$262,900$340,800
Short-Term Investments$843,100$780,500$726,400$370,500
Receivables$479,100$439,300$350,000$185,500
Inventory$57,400$38,300$35,100$30,500
Other Curr. Assets$112,100$97,800$79,100$45,500
Total Curr. Assets$1,724,700$1,607,000$1,453,500$972,800
Property Plant & Equip (Net)$592,000$347,300$145,600$155,800
Goodwill$5,700$0$0$0
Intangibles$36,500$35,500$37,200$0
Long-Term Investments$864,300$849,400$401,500$624,400
Tax Assets$485,700$362,600$305,900$315,100
Other NC Assets$9,800$49,600$25,000$4,400
Total NC Assets$1,994,000$1,644,400$915,200$1,099,700
Other Assets$0$0$0$0
Total Assets$3,718,700$3,251,400$2,368,700$2,072,500
Liabilities
Payables$110,000$133,300$67,300$51,500
Short-Term Debt$0$170,100$169,400$0
Tax Payable$0$24,400$9,000$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$397,700$327,000$292,000$194,300
Total Curr. Liab.$507,700$654,800$537,700$245,800
LT Debt$455,100$258,300$93,500$440,400
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$166,200$106,300$29,700$12,300
Total NC Liab.$621,300$364,600$123,200$452,700
Other Liabilities$0$0$0$0
Cap. Leases$455,100$258,300$93,500$105,300
Total Liabilities$1,129,000$1,019,400$660,900$698,500
Equity
Pref Stock$0$0$0$0
Common Stock$100$100$100$100
Retained Earnings$29,200-$157,100-$406,800-$635,800
AOCI$5,800$7,000-$7,900-$1,700
Other Equity$2,554,600$2,382,000$2,122,400$2,011,400
Total Equity$2,589,700$2,232,000$1,707,800$1,374,000
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,718,700$3,251,400$2,368,700$2,072,500
Net Debt$222,100$177,300$0$99,600